NCATS

The Irving Institute, a CUMC partnership with New York-Presbyterian, will fund its precision medicine program and the development of new therapies.

The funding coincides with publication of reports from the Extracellular RNA Consortium outlining growth and challenges in exosomal RNA-based diagnostics.

An NCATS License

The National Center for Advancing Translational Sciences has licensed rights to a drug to treat Niemann-Pick Type C disease, the Wall Street Journal reports.

NEW YORK (GenomeWeb) – The National Institutes of Health has awarded $17 million to fund 11 research groups seeking to develop 3-D human tissue chips that can be used to predict drug safety and effectiveness, NIH said today.

NEW YORK (GenomeWeb) – Reaction Biology said today it has received a Small Business Innovation Research grant from the National Center for Advancing Translational Sciences to create a database of epigenetic drug interactions.

NEW YORK (GenomeWeb News) – The National Center for Advancing Translational Sciences has awarded more than $79 million in Clinical and Translational Science Awards to 15 research universities around the country.

NEW YORK (GenomeWeb News) – The Albert Einstein College of Medicine of Yeshiva University and Montefiore Medical Center have received $25 million in new funding from the National Institutes of Health to fund the Harold and Muriel Block Institute for Clinical and Translational Research (ICTR) at E

NEW YORK (GenomeWeb News) – The National Heart, Lung, and Blood Institute sees rapid point-of-care devices as offering great potential to help advance personalized medicine, and it plans to fund several research projects starting next year to spur development of these tools.

NEW YORK (GenomeWeb News) – The National Institutes of Health said today that it has awarded $17 million to fund 24 new research projects seeking to understand how extracellular RNA is involved in communication between cells and how they may be used as biomarkers for diseases.

NEW YORK (GenomeWeb News) – The National Institutes of Health's Clinical and Translational Science Awards program is "contributing significantly" to the development of advancement of new clinical and translational research in the US, but some organizational changes, refocusing, and accountability

Pages

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.